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approximately the same across tests, with higher sensitivity but lower specificity. Combining abnormal tests with history accounted for 50% of mortality and 33% of each of the other outcomes. Conclusions: This is the first study to assess preoperative hemostasis screening, compared with patient history, in a large multi-center sample of adult neurosurgery patients to predict hemostasis-related outcomes. History was as predictive as laboratory testing for all outcomes, with higher sensitivity.
Routine laboratory screening appears to have limited utility. Testing limited to neurosurgical patients with a positive history would save an estimated $81,942,000 annually.
